Rationale and design of the INFUSE-AMI study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction

American Heart Journal

Volumn 161, Issue 3, 2011, Pages

  Gibson, C Michael ^a   Maehara, Akiko ^b   Lansky, Alexandra J ^b   Wohrle, Jochen ^c   Stuckey, Tom ^d   Dave, Rajesh ^e   Cox, David ^f   Grines, Cindy ^g   Dudek, Dariusz ^h   Steg, Gabriel ⁱ   Parise, Helen ⁱ   Wolff, Steven D ^b   Cristea, Ecaterina ^b   Stone, Gregg W ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e Harrisburg Hospital   (United States)

^f LEHIGH VALLEY HOSPITAL   (United States)

^g WILLIAM BEAUMONT HOSPITAL   (United States)

^h JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

ⁱ BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; HIRULOG; PRASUGREL;

ARTERY CATHETERIZATION; ARTERY THROMBOSIS; ARTICLE; CORONARY STENT; FACTORIAL DESIGN; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MYOCARDIAL PERFUSION IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS THROMBECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBUS ASPIRATION;

EID: 79952451187     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.10.006     Document Type: Article

References (50)

1. Weaver W.D., Simes R.J., and Betriu A. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. A quantitative review JAMA 278 1997 2093 2098 (Pubitemid 28016233)
2. Stone G.W., Brodie B.R., and Griffin J.J. Clinical and angiographic follow-up after primary stenting in acute myocardial infarction: the primary angioplasty in myocardial infarction (PAMI) stent pilot trial Circulation 99 1999 1548 1554 (Pubitemid 29152920)
3. Grines C.L., Cox D., and Stone G.W. A randomized trial of primary angioplasty compared to heparin-coated stent implantation for acute myocardial infarction N Engl J Med 341 1999 1949 1956 (Pubitemid 30010402)
4. Marso S.P., Miller T., and Rutherford B.D. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD trial) Am J Cardiol 100 2007 206 210 (Pubitemid 47041980)
5. Brener S.J., Barr L.A., and Burchenal J.E. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction: ReoPro and primary PTCA organization and randomized trial (RAPPORT) investigators Circulation 98 1998 734 741 (Pubitemid 28391837)
6. Montalescot G., Barragan P., and Wittenberg O. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction N Engl J Med 344 2001 1895 1903 (Pubitemid 32553358)
7. Stone G.W., Grines C.L., and Cox D. A prospective, multicenter, international randomized trial comparing four reperfusion strategies in acute myocardial infarction: principal report of the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial J Am Coll Cardiol 37 2001 648A
8. Kondo M., Nakano A., and Saito D. Assessment of "microvascular no-reflow phenomenon" using technetium-99 m macroaggregated albumin scintigraphy in patients with acute myocardial infarction J Am Coll Cardiol 32 1998 898 903 (Pubitemid 28459576)
9. Belli G., Pezzano A., and De Biase A.M. Adjunctive thrombus aspiration and mechanical protection from distal embolization in primary percutaneous intervention for acute myocardial infarction Catheter Cardiovasc Interv 50 2000 362 370 (Pubitemid 30439388)
10. Schröder R., Wegscheider K., and Schröder K. Extent of early ST-segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens J Am Coll Cardiol 26 1995 1657 1664
11. The GUSTO Angiographic Investigators The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction N Engl J Med 329 1993 1615 1622
12. Anderson J.L., Karagounis L.A., and Califf R.M. Meta analysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction Am J Cardiol 78 1996 1 8 (Pubitemid 26255441)
13. Ito H., Okamura A., and Iwakura K. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior myocardial infarction Circulation 93 1996 1993 1999 (Pubitemid 26167228)
14. Neumann F.J., Blasini R., and Schmitt C. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction Circulation 98 1998 2695 2701 (Pubitemid 28564004)
15. Costantini C.O., Stone G.W., and Mehran R. Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction J Am Coll Cardiol 44 2004 305 312 (Pubitemid 38950587)
16. De Lemos J.A., Antman E.M., and Gibson C.M. Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction: observations from the TIMI 14 study Circulation 101 2000 239 243 (Pubitemid 30054149)
17. Galiuto L., Garramone B., and Burzotta F. Thrombus aspiration reduces microvascular obstruction after primary coronary intervention: a myocardial contract echocardiography sub-study of the REMEDIA trial J Am Coll Cardiol 48 2006 1355 1360 (Pubitemid 44436805)
18. Silva-Orrego P., Colombo P., and Bigi R. Thrombus aspiration before primary angioplasty improves myocardial reperfusion in acute myocardial infarction: the DEAR-MI study J Am Coll Cardiol 48 2006 1552 1559
19. De Luca L., G Sardella G., and Davidson C.J. Impact of intracoronary aspiration thrombectomy during primary angioplasty on the left ventricular remodeling in patients with anterior ST elevation myocardial infarction Heart 92 2006 951 956
20. Vlaar P.J., Svilaas T., and van der Horst I.C. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in acute myocardial infarction Study (TAPAS): a 1-year follow-up study Lancet 371 2008 1915 1920 (Pubitemid 351778190)
21. Inaba Y., Chen J.A., and Mehta N. Impact of single or multicentre study design on the results of trials examining the efficacy of adjunctive devices to prevent distal embolisation during acute myocardial infarction EuroIntervention 5 2009 375 383
22. Kaltoft A., Bøttcher M., and Nielsen S.S. Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial Circulation 114 2006 40 47 (Pubitemid 44305273)
23. Sardella G., Mancone M., and Bucciarelli-Ducci C. Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial J Am Coll Cardiol 53 2009 309 315
24. Svilaas T., Vlaar P.J., and van der Horst I.C. Thrombus aspiration during primary percutaneous coronary intervention N Engl J Med 358 2008 557 567 (Pubitemid 351214283)
25. Collet J.P., Montalescot G., and Lesty C. Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis Arterioscler Thromb Vasc Biol 21 2001 142 148 (Pubitemid 32061939)
26. Simon D.I., Xu H., and Ortlepp S. 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1 Arterioscler Thromb Vasc Biol 17 1997 528 535 (Pubitemid 27133143)
27. Schwartz M., Nordt T., and Bode C. The GPIIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, alphaMbeta2) Thromb Res 107 2002 121 128 (Pubitemid 35341499)
28. Kupatt C., Habazettl H., and Hanusch P. C7E3Fab reduces post ischemic leukocyte-thrombocyte interaction mediated by fibrinogen: implications for myocardial reperfusion injury Arterioscler Thromb Vasc Biol 20 2000 2226 2232
29. Thuraisingham S., and Tan K.H. Dissolution of thrombus formed during direct coronary angioplasty with a single 10 mg intracoronary bolus dose of abciximab Int J Clin Pract 53 1999 604 607 (Pubitemid 30018932)
30. Bailey S.R., O'Leary E., and Chilton R. Angioscopic evaluation of site-specific administration of ReoPro Cathet Cardiovasc Diagn 42 1997 181 184
31. Bartorelli A.L., Trabattoni D., and Galli S. Successful dissolution of occlusive coronary thrombus with local administration of abciximab during PTCA Catheter Cardiovasc Interven 48 1999 211 213 (Pubitemid 29458325)
32. Shlaifer J.D., Horgan W., and Malkowski M.J. Acute antithrombotic occlusion of the left main coronary artery in a hypercoagulable patient treated with intracoronary abciximab Clin Cardiol 24 2001 788 (Pubitemid 33139573)
33. Barsness G.W., Buller C., and Ohman E.M. Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts Am Heart J 139 2000 824 829 (Pubitemid 30305404)
34. Wohrle J., Grebe O.C., and Nusser T. Reduction of adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty Circulation 107 2003 1840 1843 (Pubitemid 36444121)
35. Kakkar A.K., Moustapha A., and Hanley H.G. Comparison of intracoronary vs. intravenous administration of abciximab in coronary stenting Catheter Cardiovasc Interv 61 2004 31 34 (Pubitemid 38036787)
36. Thiele H., Schindler K., and Friedenberger J. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. The randomized leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial Circulation 118 2008 49 57
37. Deibele A.J., Jennings L.K., and Tcheng J.E. Intracoronary eptifibatide bolus administration during percutaneous coronary revascularization for acute coronary syndromes with evaluation of platelet glycoprotein IIb/IIIa receptor occupancy and platelet function: the Intracoronary Eptifibatide (ICE) trial Circulation 121 2010 784 791
38. Gibson C.M., Zorkun C., and Kunadian V. Intracoronary administration of abciximab in ST-elevation myocardial infarction Circulation 118 2008 6 8
39. Kunadian V., Zorkun C., and Williams S.P. Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction J Thromb Thrombolysis 26 2008 234 242
40. Romagnoli E., Burzotta F., and Trani C. Rationale for intracoronary administration of abciximab J Thromb Thrombolysis 23 2007 57 63
41. Saraf S., Ong P.J., and Gorog D.A. ClearWay RX-Rapid exchange therapeutic perfusion catheter EuroIntervention 3 2008 639 642
42. Capodanno D., Prati F., and Pawlowsky T. ClearWay RX system to reduce intracoronary thrombus in patients with acute coronary syndromes according to optical coherence tomography after abciximab intracoronary local infusion trial (COCTAIL): study rationale and design J Cardiovasc Med (Hagerstown) 11 2010 130 136
43. Prati F., Ramazzatti V., and Gil R. COCKTAIL study: optimal treatment of intracoronary thrombosis with local abciximab infusion through the ClearWay system San Francisco: Transcatheter Cardiovascular Therapeutics-TCT Conference; Sept 21-25 2009
44. Stone G.W., Witzenbichler B., and Guagliumi G. Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230 (Pubitemid 351724451)
45. Mehran R., Lansky A.J., and Witzenbichler B. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial Lancet 374 2009 1149 1159
46. Gersh B.J., Stone G.W., and White H.D. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? JAMA 293 2005 979 986 (Pubitemid 40271130)
47. The Thrombolysis in Myocardial Infarction (TIMI) trial Phase I findings. TIMI Study Group N Engl J Med 312 1985 932 936
48. van 't Hof A.W., Liem A., and Suryapranata H. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group Circulation 97 1998 2302 2306 (Pubitemid 28280383)
49. Schröder R., Dissmann R., and Bruggemann T. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction J Am Coll Cardiol 24 1994 384 391 (Pubitemid 24246537)
50. The ISAM Study Group A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM). Mortality, morbidity, and infarct size at 21 days N Engl J Med 314 1986 1465 1471